Most Recent
The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to invalidate the patents for its blockbuster cancer drug Revlimid, saying it could distort competition between generic drug makers.
Concrete repair company Vector Corrosion Technologies has lost its bid for ownership of a concrete treatment patent held by three former employees who jumped ship, with a court finding the trio invented the technology after leaving Vector.
A judge has signed off on a settlement in a trade mark spat between M&M candy maker Mars and the world's largest macadamia grower, Macquis Macadamias, under which Marquis will no longer seek to register its MM mark for chocolate bars.
7-Eleven has told a court it is willing to negotiate a deal with Seven over the 7NOW logo, a trade mark the TV network recently lost after a successful challenge by the convenience store chain.
The Full Federal Court has upheld US biotech company Sequenom's patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic's argument that the patent merely described a way to extract incorporeal genetic information.
Chevron has mostly failed in its lawsuit accusing Australian petrol station company Ampol of infringing its Caltex trade marks, with a judge finding that Chevron's case sought exclusive use over the colour red and was "at odds with commercial sense".
Petrol station operator Ampol has denied accusations by US oil giant Chevron that it is misusing Caltex branding on 175 of its service stations, on the first day of a trial that could see the presiding judge take a road trip to view the alleged offending signage firsthand.
A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing strike out and summary dismissal applications by the drug makers.
US biotech company Gen-Probe's bid for the removal of rival Beckman Coulter's 'Access' trade marks will be heard alongside its appeal of a ruling from the Trade Marks Office denying the company's bid to expand its 'Open Access' trade mark to Australia.
A trade mark dispute between US oil giant Chevron and Australian petrol station operator Ampol has been set down for an expedited hearing in April, ahead of which the companies have been ordered into mediation.